It is important to note that although proteinuria reduction is believed to be beneficial in proteinuric glomerular diseases in general, the magnitude of change that predicts benefit on the rate of loss of kidney function or progression to kidney failure may be different for each disease; for C3G, this relationship is not well understood. Here, RAPGEF1 is linked to kidney failure.